In addition to LFA-1, inhibition of another integrin, the very late antigen-4 (VLA-4), which is composed of CD49b (α-subunit) and CD29 (β-subunit), has shown clear neuroprotective properties in animal studies, although this effect has not been consistent across different stroke models [21,22]. The gene discussed is ITGB2; the disease is stroke disorder.